Bynfezia Pen Interactions
There are 166 drugs known to interact with Bynfezia Pen (octreotide), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 6 are major, 148 are moderate, and 12 are minor.
- View all 166 medications that may interact with Bynfezia Pen
- View Bynfezia Pen alcohol/food interactions (1)
- View Bynfezia Pen disease interactions (7)
Most frequently checked interactions
View interaction reports for Bynfezia Pen (octreotide) and the medicines listed below.
- Afinitor (everolimus)
- Cuprimine (penicillamine)
- Diacomit (stiripentol)
- Dibenzyline (phenoxybenzamine)
- ethinyl estradiol
- Etopophos (etoposide)
- Extavia (interferon beta-1b)
- Gonal-f RFF Redi-ject (follicle stimulating hormone)
- Haldol Decanoate (haloperidol)
- hyaluronidase
- ifosfamide
- Inderal (propranolol)
- Kalydeco (ivacaftor)
- lamivudine
- ledipasvir / sofosbuvir
- Ludiomil (maprotiline)
- mesna
- norethindrone
- Novantrone (mitoxantrone)
- Pegasys (peginterferon alfa-2a)
- PegIntron (peginterferon alfa-2b)
- pravastatin
- Proglycem (diazoxide)
- protriptyline
- Rebif Rebidose (interferon beta-1a)
- Recombinate (antihemophilic factor)
- Rescriptor (delavirdine)
- Rituxan Hycela (hyaluronidase / rituximab)
- sapropterin
- Somavert (pegvisomant)
Bynfezia Pen alcohol/food interactions
There is 1 alcohol/food interaction with Bynfezia Pen (octreotide).
Bynfezia Pen disease interactions
There are 7 disease interactions with Bynfezia Pen (octreotide) which include:
- renal dysfunction
- gallbladder/biliary dysfunction
- glucose intolerance
- heart disease
- hepatic impairment
- thyroid dysfunction
- vitamin B12 deficiency
Report options
More about Bynfezia Pen (octreotide)
- Bynfezia Pen consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Sandostatin
Sandostatin is used to treat acromegaly and to reduce flushing episodes and watery diarrhea caused ...
Parlodel
Parlodel is used for acromegaly, hyperprolactinemia, parkinson's disease
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Somatuline Depot
Somatuline Depot is used as a long-term treatment for acromegaly. Learn about side effects ...
Sandostatin LAR Depot
Sandostatin LAR Depot is used for acromegaly, carcinoid tumor, vasoactive intestinal peptide tumor
Signifor
Signifor (pasireotide) is a man-made protein that is similar to somatostatin and is used to treat ...
Cycloset
Cycloset is used to treat Type 2 Diabetes. Learn about side effects, interactions and indications.
Mycapssa
Mycapssa (octreotide) is used for the treatment of acromegaly. Includes Mycapssa side effects ...
Pasireotide
Pasireotide systemic is used for acromegaly, cushing's syndrome
Lanreotide
Lanreotide (Somatuline Depot) is an injectable medication containing a man-made (synthetic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
